BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 21525824)

  • 1. Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience.
    Saulino M
    Eur J Phys Rehabil Med; 2012 Mar; 48(1):39-45. PubMed ID: 21525824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.
    Natale M; Mirone G; Rotondo M; Moraci A
    Clin Neurol Neurosurg; 2012 May; 114(4):321-5. PubMed ID: 22104692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief.
    McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP
    Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.
    Mathur SN; Chu SK; McCormick Z; Chang Chien GC; Marciniak CM
    PM R; 2014 Jun; 6(6):506-513.e1. PubMed ID: 24355547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; Pittalà G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases.
    Harned ME; Salles SS; Grider JS
    Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentiation pain.
    Gatscher S; Becker R; Uhle E; Bertalanffy H
    Acta Neurochir Suppl; 2002; 79():75-6. PubMed ID: 11974992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of intrathecal baclofen (ITB) therapy in spacticity.
    Ucar T; Kazan S; Turgut U; Samanci NK
    Turk Neurosurg; 2011 Jan; 21(1):59-65. PubMed ID: 21294093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
    Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
    Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
    Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
    PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.
    Turner M; Nguyen HS; Cohen-Gadol AA
    J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrathecal baclofen therapy to spasticity].
    Mizusawa H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):951-3. PubMed ID: 18210845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intrathecal baclofen for treatment of severe spasticity in selected patients with motor neuron disease.
    Bethoux F; Boulis N; McClelland S; Willis MA; Hussain M; Machado A; Mychkovsky L; Stough D; Sutliff M; Pioro EP
    Neurorehabil Neural Repair; 2013; 27(9):828-33. PubMed ID: 23884016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.